氣道正壓通氣裝置的全球市場 - 市場規模（按細分市場）、份額、監管、報銷、運行設備數量、預測（~2033 年）

除了流行病學的考量之外，這些配件的技術進步正在推動氣道正壓裝置市場的成長。 該市場的一個主要挑戰是缺乏對呼吸系統疾病的認識，導致大量人群未被診斷和治療。

本報告研究分析了全球氣道正壓裝置市場，並提供了各細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 的影響等資訊。

市場模型的主要內容如下。

市面上已有的氣道正壓通氣裝置以及不斷變化的競爭格局

• 對主要產業趨勢的考慮
• 依氣道正壓通氣設備市場細分的年收入與市場前景（2015-2033 年）
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

• 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
• 氣道正壓通氣裝置市場的SWOT分析
• 氣道正壓裝置市場競爭動態的考量與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技監理狀況

目標公司

• Philips Respironics Inc
• ResMed Inc
• Fisher & Paykel Healthcare Corporation Ltd
• Vyaire Medical Inc
• Teijin Ltd
• DeVilbiss Healthcare LLC
• Breas Medical AB
• Koike Medical Co Ltd
• 其他

Positive Airway Pressure Devices Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on the Positive Airway Pressure Device market for the year 2020 and beyond. Positive Airway Pressure Devices are commonly used in hospitals, home settings, and long-term care facilities. The devices are available from device manufacturers and third-party suppliers. In addition to epidemiological considerations, technological advancement in these accessories drives the growth of the market. The lack of awareness of respiratory conditions leading to a large undiagnosed and untreated population is the major challenge in this market.

Each of the covered 39 country's color-coded and fully-sourced market models is equipped with epidemiology-based indications with procedure volumes. To increase the data transparency, the interactive Excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Positive Airway Pressure Device and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Positive Airway Pressure Device market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Positive Airway Pressure Device market.
• Competitive dynamics insights and trends provided for the Positive Airway Pressure Device market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Philips Respironics Inc, ResMed Inc, Fisher & Paykel Healthcare Corporation Ltd, Vyaire Medical Inc, Teijin Ltd, DeVilbiss Healthcare LLC, Breas Medical AB, Koike Medical Co Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Positive Airway Pressure Device to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Positive Airway Pressure Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Positive Airway Pressure Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Positive Airway Pressure Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Positive Airway Pressure Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable